Toronto Dominion Bank
CERE

Toronto Dominion Bank’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Toronto Dominion Bank’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-38,051
Closed -$1.23M – 2114
2021
Q4 		$1.23M Buy
+38,051
New +$1.34M ﹤0.01% 971

Other funds holding CERE

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Toronto Dominion Bank's CERE Position: Q1 2022 in Review

Toronto Dominion Bank sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q1 2022, closing a stake of 38,051 shares — an estimated $1.23M sold.

Toronto Dominion Bank first reported a position in CERE in Q4 2021 and held it in 1 quarter. The position peaked at $1.23M in Q4 2021. 107 funds tracked by Wall St. Rank hold CERE as of Q1 2022.

  • Toronto Dominion Bank reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Toronto Dominion Bank sold 38,051 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q1 2022, an estimated $1.23M.
  • Toronto Dominion Bank first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Toronto Dominion Bank's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.23M in Q4 2021.
  • 107 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q1 2022.

Based on Toronto Dominion Bank's 13F filing for Q1 2022, filed 9 May 2022.